An open-label, randomized, 3-way crossover study to assess the effect of Colesevelam HCl (WelcholA) 3750 mg on the single dose pharmacokinetics of Glipizide ER 20 mg in healthy human adult subjects
Phase of Trial: Phase III/IV
Latest Information Update: 28 May 2018
At a glance
- Drugs Colesevelam (Primary) ; Glipizide
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia type IIa; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 09 Dec 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 10 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 13 Feb 2010 New trial record